⌘K
Loading ticker…
As of 2026-08-24, Eli Lilly & Co. (LLY) has a 3-month relative strength percentile of 77 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.3%, relative volume 0.58×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
LLY is in a stage 2 uptrend, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 5.6% / 18.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
LLY is held by 4 ETFs as of Jun 2026. Top owner: USMC at 2.53% weight, $88M notional. Top 3 carry $138M.
Held by 471 ETFs · $114.6B across latest filings · largest weight 21.06% (IHE).
Top 4 by value, from SEC N-PORT-P filings dated Jun 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LLY Jan avg: 1.60% median: 0.78% win: 50% σ: 7.71% n: 4 2022-04-12 → 2026-07-31 | LLY Feb avg: 5.53% median: 7.47% win: 75% σ: 12.03% n: 4 2022-04-12 → 2026-07-31 | LLY Mar avg: -2.32% median: -3.53% win: 50% σ: 10.95% n: 4 2022-04-12 → 2026-07-31 | LLY Apr avg: 4.14% median: 1.61% win: 80% σ: 8.04% n: 5 2022-04-12 → 2026-07-31 | LLY May avg: 4.22% median: 7.29% win: 80% σ: 13.38% n: 5 2022-04-12 → 2026-07-31 | LLY Jun avg: 7.45% median: 8.55% win: 100% σ: 2.83% n: 5 2022-04-12 → 2026-07-31 | LLY Jul avg: -4.37% median: -4.22% win: 20% σ: 4.61% n: 5 2022-04-12 → 2026-07-31 | LLY Aug avg: 7.91% median: 9.18% win: 50% σ: 15.07% n: 4 2022-04-12 → 2026-07-31 (current) | LLY Sep avg: 0.18% median: 0.54% win: 50% σ: 6.83% n: 4 2022-04-12 → 2026-07-31 | LLY Oct avg: 5.46% median: 7.55% win: 75% σ: 9.05% n: 4 2022-04-12 → 2026-07-31 | LLY Nov avg: 7.42% median: 4.59% win: 75% σ: 12.32% n: 4 2022-04-12 → 2026-07-31 | LLY Dec avg: -1.45% median: -1.39% win: 0% σ: 1.17% n: 4 2022-04-12 → 2026-07-31 |